The administration of β2-agonists for paediatric asthma and its adverse reaction in Australian and New Zealand emergency departments: A cross-sectional survey

European Journal of Emergency Medicine

Volumn 10, Issue 3, 2003, Pages 219-224

  Habashy, Doaa ^a   Lam, Lawrence T ^a   Browne, Gary J ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Adverse effects; Asthma; Children; Infusion; Salbutamol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL;

ADOLESCENT; ARTICLE; ASTHMA; AUSTRALIA; CHEMICALLY INDUCED DISORDER; CHILD; CROSS-SECTIONAL STUDY; DRUG POTENTIATION; DRUG UTILIZATION; EMERGENCY HEALTH SERVICE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; METERED DOSE INHALER; MORTALITY; NEW ZEALAND; NEWBORN; PRESCHOOL CHILD; PREVALENCE; QUESTIONNAIRE; STATISTICS; TACHYCARDIA; UTILIZATION REVIEW;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ASTHMA; AUSTRALIA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; EMERGENCY SERVICE, HOSPITAL; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; METERED DOSE INHALERS; NEW ZEALAND; PREVALENCE; QUESTIONNAIRES; RECEPTORS, ADRENERGIC, BETA-2; TACHYCARDIA;

EID: 1542464884     PISSN: 09699546     EISSN: 14735695     Source Type: Journal    
DOI: 10.1097/00063110-200309000-00012     Document Type: Article

References (31)

1. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351:1225-1232.
2. Anderson HR, Butland BK, Strachan DP. Trends in prevalence and severity of childhood asthma. BMJ 1994; 308:1600-1604.
3. Oanh LN, Hanson R, Van Asperen P. Increase in asthma severity in the West [Letter]. J Paediatr Child Health 1997; 33:459.
4. Oberklaid F, Mellis CM, Souef PN et al. A comparison of a bodyweight dose versus a fixed dose of nebulised salbutamol in acute asthma in children. Med J Aust 1993; 158:751-753.
5. Schuh S, Parkin P, Rajan A, et al. High- versus low-dose frequently administered nebulised albuterol in children with severe acute asthma. Pediatrics 1989; 83:513-518.
6. Colacone A, Wolkove N, Stern E, et al. Continuous nebulisation of albuterol in acute asthma. Chest 1990; 97:693-697.
7. Kelly HW, McWillliams BC, Katz R, et al. Safety of frequent high dose nebulised terbutaline in children with acute severe asthma. Ann Allergy 1990; 64:229-233.
8. 2 in children with severe asthma treated with continuous nebulised terbutaline. J Allergy Clin Immunol 1988; 81:1101-1109.
9. Schuh S, Reider M, Canny G, et al. Nebulised albuterol in acute childhood asthma: comparison of two doses. Pediatrics 1990; 3:509-513.
10. Scarfone RJ, Fuchs SM, Nager AL, Share SS. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics 1993; 92:512-518.
11. Connett GJ, Warde C, Wooler E, Lenney W. Prednisolone and salbutamol in the hospital treatment of acute asthma. Arch Dis Child 1990; 65:407-410.
12. Dewar AL, Stewart A, Cogswell JJ, Connett GJ. A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital. Arch Dis Child 1999; 80:421-423.
13. Browne GJ, Phin SJ, Chin R. What every emergency physician needs to know about childhood asthma. Emerg Med 2001; 13:436-443.
14. Browne GJ, Penna AS, Phung X, Soo M. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet 1997; 349:301-305.
15. Born D, Kalloghlian A, Jenkins J, et al. Intravenous salbutamol in the treatment of status asthmaticus in children. Crit Care Med 1984; 12:892-896.
16. Stephanopoulos DE, Monge R, Schell KH, et al. Continuous intravenous terbutaline for pediatric status asthmaticus. Crit Care Med 1998; 26:1744-1748.
17. Australasian College of Emergency Medicine (ACEM). Training guidelines: document on hospitals with emergency departments approved for advanced training. Victoria, Australia: Australian College of Emergency Medicine; 2000.
18. Asthma Management Handbook. National Asthma Council Australia. http://www.NationalAsthma.org.au. 1998. (Revised and update 2002. Last used 5th June 2003)
19. Chou KJ, Cunningham SJ, Crain EF. Metered dose inhalers with spacers vs nebulisers for paediatric asthma. Arch Paediatr Adolesc Med 1995; 149:201-205.
20. Kerem E, Levison H, Schuh S, et al. Efficacy of albuterol administered by nebuliser versus spacer device in children. J Pediatr 1993; 123:313-317.
21. Dewar AL, Stewart A, Cogswell JJ, Connett GJ. A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute ashtma in hospital. Arch Dis Child 1999; 80:421-423.
22. Powell CVE, Maskell GR, Marks MK, et al. Successful implementation of spacer treatment guidelines for acute asthma. Arch Dis Child 2001; 84:142-146.
23. Cheng NG, Browne GJ, Lam LT, et al. Spacer compliance after discharge following a mild to moderate asthma attack. Arch Dis Child 2002; 87:302-305.
24. Chua S, Razvi K, Wong MT, et al. Is there a need to treat hypokalaemia associated with intravenous salbutamol infusion? J Obstet Gynaecol Res 1997; 23:381-387.
25. Du Plooy WJ, Hay L, Kahler CP, et al. The dose-related hyper- and hypokalaemic effects of salbutamol and its arrhythmogenic potential. Br J Pharmacol 1994; 111:73-76.
26. Singhi SC, Jayashree K, Sarkar B. Hypokalaemia following nebulised salbutamol in children with acute attack of bronchial asthma. J Paediatr Child Health 1996; 32:495-497.
27. Chih-Hsing H, Der-Ming C, Chih-Lu W, et al. Hypokalaemia and salbutamol therapy in asthma. Pediatr Pulmonol 1999; 27:27-31.
28. Scalabrin DM, Sole D, Nasitz CK. Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol. J Asthma 1996; 33:407-415.
29. Craig VL, Bigos D, Brilli RJ. Efficacy and safety of continuous albuterol nebulisation in children with severe status asthmaticus. Pediatr Emerg Care 1996; 12:1-5.
30. Tunaoglu FS, Turtas I, Olgunturk R, Demirsoy S. Cardiac side effects of long-acting beta 2-agonist salmeterol in asthmatic children. Pediatr Int 1999; 41:28-31.
31. Australian Bureau of Statistics. Document released by the Asthma Foundation. Canberra, Australia: Australian Bureau of Statistics; 2000.